This is an old revision of this page, as edited by Citation bot(talk | contribs) at 20:27, 4 October 2021(Add: doi-access. | Use this bot. Report bugs. | Suggested by Headbomb | Linked from Wikipedia:WikiProject_Academic_Journals/Journals_cited_by_Wikipedia/Sandbox | #UCB_webform_linked 71/732). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 20:27, 4 October 2021 by Citation bot(talk | contribs)(Add: doi-access. | Use this bot. Report bugs. | Suggested by Headbomb | Linked from Wikipedia:WikiProject_Academic_Journals/Journals_cited_by_Wikipedia/Sandbox | #UCB_webform_linked 71/732)
Muscarinic toxin 7 (MT7) is one member of a family of small peptides of 65 amino acidresidues
derived from the venom of African mamba snakes (Dendroaspis angusticeps), which mainly target M1-subtype of muscarinic receptor. Muscarinic toxins like the nicotinic toxins have the three-finger fold structure, characteristic of the large superfamily of toxins that act at cholinergic synapses.
Muscarinic toxin 7
Crystal structure of Muscarinic toxin 7 (MT7) from PDB 2VLW [1]
MT7 is likely to bind to the human M1 receptor in its dimer form with the tips of MT7 loops II and III contacting one hM1 protomer and the tip of loop I binds to the other protomer.[2]
References
^Fruchart-Gaillard C, Mourier G, Marquer C, Stura E, Birdsall NJ, Servent D (December 2008). "Different interactions between MT7 toxin and the human muscarinic M1 receptor in its free and N-methylscopolamine-occupied states". Mol. Pharmacol. 74 (6): 1554–63. doi:10.1124/mol.108.050773. PMID18784346. S2CID9480977.
